← Evidence map

ArticleDrugs - real world outcomes2026

Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study.

Yoshiki Hanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study. | OpenQuestion